Matts Johansen, CEO of Aker BioMarine ASA, has through KMMN Invest II AS, a
company controlled by Mr. Johansen, today purchased 14,000 shares in Aker
BioMarine ASA at an average price of NOK 35,05 per share. Following the
transaction, Mr. Johansen, directly and indirectly, controls 1,094,958 shares in
Aker BioMarine ASA.

Please see attached primary insider notification form pursuant to the
requirements of the Market Abuse Regulation ("MAR").

This information is subject to the disclosure requirements pursuant to MAR
Article 19 and Section 5-12 of the Norwegian Securities Trading Act.